Renese-r

   
Google
 
Web NewDrugInformation.com

Renese-r


Drug - Renese-r
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Polythiazide; Reserpine
Multiple ingredients are in alphabetical order.

Strength - 2MG;0.25MG
The potency of the active ingredient(s), Polythiazide; Reserpine. May repeat for multiple part products.

Applicant - PFIZER
The firm name holding legal responsibility for Renese-r. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 013636
The FDA assigned number to Renese-r. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Renese-r. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Renese-r was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Renese-r. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Renese-r is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pfizer Laboratories Div Pfizer Inc
The full name of the firm holding legal responsibility for the new application of Renese-r.

Renese-r